Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comparison of exon-wise expression profiling between normal and cancer tissues of human stomach

ABSTRACT: Gastric cancers account for the fourth most frequent cancer death worldwide. Although many differential gene expression profiles are reported for gastric cancers, their variation at the post-transcriptional level has not been provided yet. In this study, we compared the gene expressions of normal stomach vs. stomach cancer in an exon-wise manner and compared alternatively spliced transcripts. The RNA from normal and cancer tissues of gastric cancer patients were subjected to Exon 1.0 ST microarrays.

ORGANISM(S): Homo sapiens

PROVIDER: GSE30727 | GEO | 2014/07/12

SECONDARY ACCESSION(S): PRJNA144357

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Comparison of exon-wise expression profiling between normal and cancer tissues of human stomach

Project description:Gastric cancers account for the fourth most frequent cancer death worldwide. Although many differential gene expression profiles are reported for gastric cancers, their variation at the post-transcriptional level has not been provided yet. In this study, we compared the gene expressions of normal stomach vs. stomach cancer in an exon-wise manner and compared alternatively spliced transcripts. The RNA from normal and cancer tissues of gastric cancer patients were subjected to Exon 1.0 ST microarrays. Transcriptome analysis of RNAs from normal and cancer tissues of human stomach by exon array. We analyzed 30 pairs of normal-cancer stomach tissues using the Affymetrix Human Exon 1.0 ST platform. Array data was processed by the Affymetrix Exon Array Computational Tool.

2014-07-12 | E-GEOD-30727 | biostudies-arrayexpress

MicroRNA profiling of human normal stomach and gastric cancer samples to investigate the role of miRNA involvement in stomach carcinogenesis

Project description:MicroRNA (miRNA) expression profiles for gastric cancers were examined to investigate the miRNA involvement in stomach carcinogenesis. miRNA microarray analysis identified statistical unique profiles, which could discriminate stomach cancers from noncancerous stomach tissues.

2005-12-31 | E-TABM-50 | biostudies-arrayexpress

stomach metagenome

Project description:stomach microbiome shape in two gastric cancer subtypes

| PRJNA641258 | ENA

miRNA analysis in myofibroblats derived from normal stomach, both antrum (A) and corpus (C) separately and gastric cancers

Project description:We prepared miRNA from myofibroblats derived from normal stomach, both antrum (A) and corpus (C) separately and gastric cancers. miRCURYTM LNA Array ver5 was performed and comparisons were made by the dual (reference) method.

2016-02-01 | GSE76218 | GEO

A region-resolved mucosa proteome of the human stomach

Project description:The human gastric mucosa is the most active and functional layer that carries out food digestion and metabolic processes in physiological conditions and also the main origin of carcinogenesis in gastric cancer. Anatomically, the human stomach is divided into 7 regions with physiological functions, but the protein basis for cellular specialization is not well understood. Here we present a global analysis of protein profiles of 80 apparently normal mucosas obtained by endoscopic biopsy of stomach. We identified 11,597 proteins and provided an estimation of protein expression variations/ranges in the 7 regions of the human stomach. To our knowledge, this is the first region-resolved, near normal tissue proteome reference map obtained from living individuals. We also measured mucosa protein profiles of tumor and tumor nearby tissues (TNT) from 54 gastric cancer patients, allowing for comparisons between tumor, TNT, and normal tissues. These datasets provide a rich resource for the gastrointestinal tract research community to investigate the molecular basis for region specific functions in mucosa physiology and pathology including gastric cancer.

2018-11-26 | PXD011821 | iProX

Stomach-specific c-Myc overexpression drives intestinal-type gastric cancer in mice via AKT/mTOR signaling

Project description:Gastric cancer (GC) is one of the most common malignant cancers in the world. c-Myc, a well-known oncogene, is commonly amplified in many cancers, including gastric cancer. However, it is still not completely understood how c-Myc functions in GC. Here, we generated a stomach-specific c-Myc knock-in mouse model to investigate its role in GC. We found that overexpression of c-Myc in Atp4b+ gastric parietal cells could induce intestinal-type gastric cancer in mice. Mechanistically, c-Myc promoted tumorigenesis via the AKT/mTOR pathway. Furthermore, AKT inhibitor (MK-2206) or mTOR inhibitor (Rapamycin) inhibited the proliferation of c-Myc overexpressing gastric cancer cell lines. Thus, our findings highlight that gastric cancer can be induced by c-Myc overexpression through activation of the AKT/mTOR pathway.

2021-08-11 | GSE145583 | GEO

Gene expression studies in apparently normal, paired normal and malignant gastric tissues

Project description:Gene expression profiling of apparently normal gastric tissue (obtained from patients undergoing gastric surgery for Non-gastric cancers), paired normals (obtained from the same stomach as the gastric cancer but confirmed by frozen section not to harbour any tumour cells) and gastric cancer, with an intent to identify genes involved in the malignant transformation of normal gastric mucosa and to identify genes which can be used as biomarkers for early diagnosis and potential targets for treatment Identification of novel prognostic markers using microarray gene expression studies. Keywords: Patient tissue samples Two-dye experiments using Universal control RNA (Stratagene) and RNA from tissues. Biological replicates: Apparently Normal = 5; Paired Normal = 20; Gastric cancers = 24. One replicate per array.

2010-11-30 | E-GEOD-17154 | biostudies-arrayexpress

Homo sapiens

Project description:Comparison of exon-wise expression profiling between normal and cancer tissues of human stomach

| PRJNA144357 | ENA

Transcriptional profiles of stomach organoids from human embryonic stem cells.

Project description:Gastric ulcer, which affect many of patients and is deeply related with gastric cancer, is caused by chronic gastric acid stimulation. Stomach fundus, the main body of stomach, is a major source of gastric acid and peptidase for food digestion. Recapturing the main body of stomach requires mainly 3 functionally differentiated cells; parietal (oxyntic) cells, chief (zymogenic) cells, and surface mucous foveolar (pit) cells. We have previously shown the induction of stomach tissue with functional secreting activities by directed differentiation of mouse embryonic stem cells (ES cells) to stomach primordium with both gut epithelium and splanchnic mesoderm. However, generating human stomach with fundus and such functions has been elucidated and a long-desired goal. Here, we describe the method for establishing human embryonic stem cell-derived stomach organoids with fundus gland structure. Along with mouse stomach development and de novo stomach generation from mouse ES cells in vitro, we observed gut-like structure formation from human embryonic stem cells by induction of both endoderm and mesoderm. These human embryonic gut could differentiate into stomach primordium by growth factor stimulation as well as stomach development, and form stomach tissue in three-dimensional organoid culture. Furthermore, these stomach organoids contain fundus-like gland with parietal cells and chief cells, some of secreting activities, and is transcriptionally close to human stomach. Human functional stomach derived from embryonic stem cells represent powerful tools for analying human stomach development, and gastric ulcer related disease including gastric tumorgenesis.

2017-08-31 | GSE79673 | GEO

Comparative genomic hybridization of non-tumor stomach tissue from gastric cancer patients

Project description:Non-tumor stomach tissue from gastric cancer patients.

2007-03-27 | E-SMDB-3964 | biostudies-arrayexpress